تعديل

Affichage des articles dont le libellé est Bristol-Myers shares could rise 25 percent on cancer drug: Barron's. Afficher tous les articles
Affichage des articles dont le libellé est Bristol-Myers shares could rise 25 percent on cancer drug: Barron's. Afficher tous les articles

dimanche 14 février 2016

Bristol-Myers shares could rise 25 percent on cancer drug: Barron's

NEW YORK (Reuters) - Shares of Bristol-Myers Squibb could rise 25 percent within a year because of its cancer-fighting drug Opdivo, which some analysts see generating $8 billion to $9 billion in annual sales in five years, Barron's said in its latest edition.











http://ift.tt/1RD07O2

from Reuters: Health News
via animenewspro